Aquatic Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Buy
+2,644
New +$1.48M 0.05% 469
2025
Q4
– Sell
-8,299
Closed -$5.3M – 1562
2025
Q3
$5.3M Buy
+8,299
New +$5.04M 0.1% 251
2024
Q4
– Sell
-240
Closed -$121K – 1465
2024
Q3
$121K Buy
+240
New +$117K ﹤0.01% 898
2024
Q1
– Sell
-6,160
Closed -$3.42M – 1410
2023
Q4
$3.42M Sell
6,160
-9,360
-60% -$4.39M 0.09% 229
2023
Q3
$6.79M Buy
+15,520
New +$7.74M 0.28% 92
2023
Q1
– Sell
-10,600
Closed -$4.32M – 1488
2022
Q4
$4.32M Buy
+10,600
New +$4.11M 0.32% 74
2022
Q3
– Sell
-700
Closed -$246K – 1348
2022
Q2
$246K Buy
+700
New +$285K 0.08% 289

Other funds holding IDXX

Aquatic Capital Management's IDXX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 2,644 shares worth $1.39M. The stake represents 0.05% of the portfolio and ranks #469 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in IDXX as recently as Q3 2025.

Aquatic Capital Management first reported a position in IDXX in Q2 2022 and has held it in 7 quarters since. The position peaked at $6.79M in Q3 2023. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Aquatic Capital Management held 2,644 shares of Idexx Laboratories worth $1.39M as of Q2 2026.
  • Idexx Laboratories was a new Aquatic Capital Management position in Q2 2026.
  • Idexx Laboratories made up 0.05% of Aquatic Capital Management's portfolio in Q2 2026, its #469 holding.
  • Aquatic Capital Management first reported a position in Idexx Laboratories in Q2 2022 and has held it in 7 quarters since.
  • Aquatic Capital Management's Idexx Laboratories position peaked at $6.79M in Q3 2023.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.